Tenderwize
Back to tender search

Open house Arzneimittelrabattverträge Sorafenib, ATC L01EX02

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Sep 05, 2026 · 60 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Sorafenib, ATC L01EX02

60/100

Opportunity Score

PromisingLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

60 / 100

Complexity

20 / 100

Risk factors

The open-house agreement may be terminated if a standard discount contract is concluded for Sorafenib, potentially redu...

No estimated value or guaranteed volume is disclosed. The discount may not generate sufficient revenue without committe...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Oct 2026
  • Non-exclusive drug discount agreements for Sorafenib (ATC L01EX02) with AOK Bayern.
  • Agreements are identical and non-negotiable for all participants.
Show full summary

This is an open-house model (not a competitive tender) by AOK Bayern for non-exclusive drug discount agreements on the active ingredient Sorafenib (ATC L01EX02) under §130a Abs. 8 SGB V. Any eligible pharmaceutical company can join by submitting a signed contract and a self-declaration of reliability. Contracts run from 01.11.2024 to 31.10.2026, with possible earlier termination if a standard discount contract comes into effect. No estimated value is provided.

Risks

The open-house agreement may be terminated if a standard discount contract is concluded for Sorafenib, potentially redu...

No estimated value or guaranteed volume is disclosed. The discount may not generate sufficient revenue without committe...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • If signing authority is not evident from the commercial register, a power of attorney must be provided.

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • Submission of a signed contract (in duplicate if in writing) and a signed self-declaration of reliability.

Requirements may be incomplete.

Buyer

Name

AOK Bayern - Die Gesundheitskasse

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Sorafenib, ATC L01EX02

Non-exclusive discount agreements for Sorafenib. Open to all interested pharmaceutical companies meeting the eligibility criteria. No selection or award criteria – all eligible participants are accepted.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Oct 2024 - Oct 2026

Category

Pharmaceutical products

Deadline

Deadline Sep 05, 2026

Procurement Details

Publication date
16 Sep 2024
Notice type
Contract notice — standard
Languages
German

Reference metadata

Notice subtype
16
Notice version
1
Legal basis
32014L0024

Reference IDs

Tender ID
557828-2024

Documents (2)

Similar tenders